ENTITY
CanariaBio

CanariaBio (016790 KS)

53
Analysis
Consumer Staples • South Korea
CANARIABIO Inc. operates as a new anticancer drugs development biotechnology company. The Company develops ovarian cancer, pancreatic cancer, gynecological cancer, and metastatic breast cancer immunotherapy drugs. CANARIABIO also produces sheep, pig, hog, poultry, and sweetened feed products.
more
•23 Mar 2024 03:42

Special Changes in KOSDAQ 150: Deletion (CanariaBio) + Addition  (C&C International)

On 22 March, the Korea Exchange announced special changes to KOSDAQ 150. CanariaBio will be excluded from KOSDAQ 150 and it will be replaced by C&C...

Logo
840 Views
Share
bearish•Doosan Robotics
•31 Oct 2023 16:23

End of Mandatory Lock-Up Periods for 48 Companies in Korea in November 2023

We discuss the end of the mandatory lock-up periods for 48 stocks in Korea in November 2023, among which 6 are in KOSPI and 42 are in KOSDAQ.

Logo
522 Views
Share
•27 Sep 2023 16:36

End of Mandatory Lock-Up Periods for 45 Companies in Korea in October 2023

We discuss the end of the mandatory lock-up periods for 45 stocks in Korea in October 2023, among which 2 are in KOSPI and 43 are in KOSDAQ.

Logo
729 Views
Share
•27 Sep 2023 14:05

Details About KOSPI & KOSDAQ Lock-Up Release Stocks for October

This post provides information regarding the October lock-up release stocks in KOSPI and KOSDAQ and explores the stocks requiring our special...

Logo
774 Views
Share
bearish•CJ CGV Co Ltd
•31 Jul 2023 13:46

End of Mandatory Lock-Up Periods for 40 Companies in Korea in August 2023

We discuss the end of the mandatory lock-up periods for 40 stocks in Korea in August 2023, among which 2 are in KOSPI and 38 are in KOSDAQ.

Logo
477 Views
Share
x